L. Banerji

发表

BCR signals target p27Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells

E. Lam, J. Glassford, L. Banerji, 2001, Oncogene.

The influence of INK 4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells

John L. Lewis, E. Lam, J. Goldman, 2001 .

The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells.

E. Lam, J. Goldman, N. Cross, 2001, Blood.

Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors

E. Lam, A. Pizzey, J. Glassford, 1999, European journal of immunology.

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.

D. Fabbro, J. Kutok, J. Fletcher, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.

E. Lam, G. Peters, J. Melo, 2001, Cancer research.

BCR-ABL and Interleukin 3 Promote Haematopoietic Cell Proliferation and Survival through Modulation of Cyclin D2 and p27Kip1 Expression*

E. Lam, E. Lam, C. Rivas, 2001, The Journal of Biological Chemistry.

Cyclin D2 controls B cell progenitor numbers

E. Lam, G. Mufti, J. Glassford, 2003, Journal of leukocyte biology.

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.

D. Fabbro, J. Griffin, A. Kung, 2007, Blood.

Cyclin D 3 Compensates for Loss of Cyclin D 2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD 40 *

E. Lam, P. Sicinski, J. Glassford, 2000 .

Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias

M. Sattler, L. Banerji, 2004, Expert opinion on therapeutic targets.

Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40*

E. Lam, P. Sicinski, J. Glassford, 2000, The Journal of Biological Chemistry.

Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.

J. Griffin, I. Galinsky, A. Kung, 2008, Blood.

Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27KIP1

J. Lammers, E. Lam, R. Medema, 2000, Molecular and Cellular Biology.

Vav Is Required for Cyclin D2 Induction and Proliferation of Mouse B Lymphocytes Activated via the Antigen Receptor*

J. Glassford, L. Banerji, G. Klaus, 2001, The Journal of Biological Chemistry.

BCR targets cyclin D2 via Btk and the p85α subunit of PI3-K to induce cell cycle progression in primary mouse B cells

E. Lam, T. Kadowaki, J. Glassford, 2003, Oncogene.

NI1 RETROSPECTIVE ANALYSIS OF TECHNOLOGY APPRAISALS CONDUCTED BY UK'S NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN SEVERAL CANCER INDICATIONS: HIGHER EVIDENCE BARRIERS FOR TARGETED THERAPIES?

L. Banerji, S. Das, 2010 .

hematopoietic progenitor cells The influence of INK4 proteins on growth and self-renewal kinetics of

J. Goldman, J. Glassford, L. Banerji, 2013 .